Visual Outcome of Intravitreal Bevacizumab in Treatment of Diabetic Retinopathy
Background :To evaluate the efficacy of monthly intravitreal bevacizumab injections (1.25 mg/.05 ml) in improving or stabilizing visual acuity measured by Snellen’s visual acuity charts for diabetic retinopathy. Methods: This was a prospective Quasi experimental study of 59 diabetic patients having...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2018-03-01
|
Series: | Journal of Rawalpindi Medical College |
Subjects: | |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/840 |